Author:
Gish Robert G.,Arora Sanjeev,Rajender Reddy K.,Nelson David R.,O’Brien Christopher,Xu Yi,Murphy Brian
Reference21 articles.
1. World Health Organization. Hepatitis C [Fact sheet No. 164]. Updated: October, 2000. Available at: http://www.who.int/mediacentre/factsheets/fs164/en/. Accessed: March 6, 2007.
2. National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C: 2002 – June 10–12, 2002. Hepatology 2002;36 Suppl 1:S3-S20.
3. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002;Armstrong;Ann Intern Med,2006
4. Manns MP, McHutchison JG, Gordon SC, Rustgi VK, Shiffman M, Reindollar R, et al., and The International Hepatitis Interventional Therapy Group, Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 2001;358:958–965.
5. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection;Fried;N Engl J Med,2002
Cited by
41 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献